H-CPR QCDR

Improving the Quality of Hospital-Based Care

We are dedicated to improving the quality of hospital-based care across the country by reporting and sharing performance and quality data. We believe that direct provider feedback on performance and quality indicators improves patient care.

Hospitalist Medicine Qualified Clinical Data Registry (H-CPR)

MedAmerica (d/b/a Vituity) has been approved to become a Qualified Clinical Data Registry (QCDR) by the Centers for Medicare and Medicaid Services (CMS). The Hospitalist – Clinical Performance Registry (H-CPR) supports all MIPS Clinical Quality Measures (CQMs), Promoting Interoperability Measures, and Improvement Activities. The measures tracked in our Hospitalist-Clinical Performance Registry (H-CPR) are listed below.

H-CPR QCDR Measures

View the detailed measure specifications for the Non-MIPS QCDR measures.

(Updated December 2021)

Measure #	Measure Title
Hospitalist Measures
HCPR14	Venous Thromboembolism (VTE) Prophylaxis
HCPR23	Avoidance of Echocardiogram and Carotid Ultrasound for Syncope
HCPR24	Appropriate Utilization of Vancomycin for Cellulitis
ECPR51	Discharge Prescription of Naloxone after Opioid Poisoning or Overdose
ECPR56	Opioid Withdrawal: Initiation of Medication-Assisted Treatment (MAT) and Referral to Outpatient Opioid Treatment
SNF Measures
HCPR16	Physician’s Orders for Life-Sustaining Treatment (POLST) Form
HCPR17	Pressure Ulcers – Risk Assessment and Plan of Care
HCPR18	Unintentional Weight Loss – Risk Assessment and Plan of Care
Critical Care Measures
HCPR20	Clostridium Difficile – Risk Assessment and Plan of Care
HCPR22	Critical Care Transfer of Care – Use of Verbal Checklist or Protocol

View measure specifications from previous years:

2021
2020

H-CPR Supported MIPS Measures

Measure #	Measure Title
5	Heart Failure: Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
6	Heart Failure: Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
7	Beta-Blocker Therapy-Prior MI or LVEF <40%
8	Heart Failure: Beta- Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
47	Advanced Care Plan
76	Prevention of Catheter- Related Bloodstream Infections (CRBSI): Venous Catheter (CVC) Insertion Protocol
130	Documentation of Current Medications in the Medical Record
154	Falls: Risk Assessment
155	Falls: Plan of Care

2022 Performance Year Quality Focus

Advanced Care Planning - Physician’s Orders for Life-Sustaining Treatment (POLST) Form

2022 Performance Year Quality Focus

2022 Performance Year Quality Focus

Learn More

Learn More

Questions?

Questions?

Partnering to improve patient lives